It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says - In the first ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...

The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound.